News Microbot Medical Inc.

Equities

MBOT

US59503A2042

Market Closed - Nasdaq Other stock markets 02:00:00 04/05/2024 am IST			5-day change	1st Jan Change
0.9798 ^USD	-1.87%		+11.34%	-40.26%

29/04	Microbot Medical Announces Positive Results from the First Phase of Its Collaboration with Corewell Health	CI
16/04	HC Wainwright Adjusts Microbot Medical's Price Target to $7 From $8, Keeps Buy Rating	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™	29/04	GL
Microbot Medical Announces Positive Results from the First Phase of Its Collaboration with Corewell Health	29/04	CI
HC Wainwright Adjusts Microbot Medical's Price Target to $7 From $8, Keeps Buy Rating	16/04	MT
Microbot Medical Shares Status Following Recent Geopolitical Events	15/04	GL
Microbot Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03	CI
Microbot Medical Submits US FDA Application to Start Human Clinical Trial for Robotic Surgical System	05/02	MT
Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US	05/02	GL
Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US	05/02	CI
Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters	30/01	GL
Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study	18/01	GL
Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study	18/01	AQ
Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study	18/01	CI
Sector Update: Health Care Stocks Ease Friday Afternoon	30/12	MT
Microbot Medical to Exercise Outstanding Preferred Investment Options for $2.7 Million	29/12	MT
Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules	29/12	GL
Sector Update: Health Care Stocks Rise in Late Afternoon	29/12	MT
Microbot Medical Says GLP Preclinical Study of Liberty Endovascular Robotic Surgical System Met Objectives; Shares Rise	28/12	MT
Sector Update: Health Care Stocks Advance Thursday Afternoon	29/12	MT
Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met	28/12	GL
Microbot Medical Announces Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Met	28/12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Microbot Medical Inc.

Equities

MBOT

US59503A2042

Summary

Filters